drugset / Trial / NCT01264874
MelaViD: A Trial on Vitamin D Supplementation for Resected Stage II Melanoma Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this trial is to assess the effect of vitamin D supplementation on recurrence in resected stage II melanoma patients.
Timeline
- Start
- 2010-05
- Primary completion
- 2017-07
- Completion
- 2017-07
Outcome
Outcome not reported
Stopped (Enrollment): “poor accrual rate”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 100000 iu | — |